Banking on a Shot in the Dark | Del Bigtree interviews Dr. Peter McCullough | Analysis by Dr. Joseph Mercola and Fact Checked

Video Link

STORY AT-A-GLANCE

  • In recent months, two Pfizer officials have bragged about moving vaccine science forward at a speed that disallows proper scientific protocols from being followed, and the release of reformulated mRNA COVID boosters without testing is now the norm
  • In November 2022, recently retired head of vaccine R&D at Pfizer, Kathrin Jansen, said “we flew the aeroplane while we were still building it. We couldn’t wait for data, we had to do so much at risk.” Pfizer compressed its vaccine development timeline from 10 years to a mere nine months by simultaneously developing and testing the product in human trials
  • Pfizer and other COVID jab makers hid side effects by eliminating the control groups long before the studies were over
  • Vaccine makers are readying to release other mRNA shots, many of which are being fast-tracked and predicted to receive authorization in months rather than years. Moderna is working on a three-in-one shot for COVID, flu and RSV (respiratory syncytial virus), and they seem to expect releasing it before clinical trials are finished
  • Pfizer quoted and relied on data from Israel when it sought approval from the FDA, and as it turns out, the Israeli government hid information about side effects. It didn’t even implement its surveillance system until a year after the shots rolled out, and when the data were analyzed, researchers concluded there were causative links between certain side effects and the jabs

In the video above, Del Bigtree with The Highwire reviews how the precautionary principle and long-standing safety guidelines in medicine have been eliminated with the COVID shots, and how data showing harms are being ignored, suppressed and manipulated to hide the truth.

In recent months, vaccine makers have bragged about moving vaccine science forward at a speed where proper scientific protocols will be abandoned.

Continue reading on Source: Banking on a Shot in the Dark

Advertisement